|01:00 AM ET|
FDA Partner Gary Yingling will join the American Conference Institute’s forum on Over the Counter Drugs.
Mr. Yingling’s session will explore continuing legal and regulatory conundrums associated with the Monograph System and the OTC Drug Review Process.
For over a decade, the OTC drug industry has been patiently awaiting the modernization of the FDA Monograph and OTC Review. In the interim, the industry has tried to devise work arounds in the absence of definitive guidance and often finds itself at the impasse of legal and regulatory uncertainties. This panel will explore current industry challenges and possible solutions in the void of definitive guidance. Topics will include
October 29, 2013
The Carlton Hotel
New York, NY
Please see event registration link for more information.